Oncology News

Codrituzumab was non-effective in patients who had already failed treatment for hepatocellular carcinoma, according to a phase 2 study published in the Journal of Hepatology.

An estimated 746,000 deaths occur annually from liver cancer worldwide.

Biphenotypic primary liver carcinoma — also called hepatocholangiocarcinoma — may be misclassified as hepatocellular carcinoma if interpretation is based on major imaging features alone and not additional ancillary features, according to recent findings published in the American Journal of Roentgenology.

Patients with hepatocellular carcinoma were more likely to be placed on liver transplant waitlists than other patients with end-stage liver disease, according to recent findings published in Clinical Gastroenterology and Hepatology.

Researchers at the University of Tennessee Medical Center have treated the first patient in the phase 3 clinical trial for the hepatocellular carcinoma medication Pexa-Vec, according to a press release.

In patients with hepatitis C, both atorvastatin and fluvastatin use were associated with a dose-dependent reduction in both cirrhosis and hepatocellular carcinoma, according to recent findings published in Hepatology.

Researchers from Taiwan developed a temporal mutation profile that discerned which patients with hepatitis B virus are more likely to develop hepatocellular carcinoma within 5 years, according to recent findings published in Hepatology.

Sorafenib was associated with a reduction in immune-suppressive phenotypes in patients with hepatocellular carcinoma, according to recent findings published in JCI Insight.

Patients with nonalcoholic steatohepatitis and hepatocellular carcinoma are less likely to receive a liver transplant compared with patients with hepatitis C virus and hepatocellular carcinoma, according to recent findings published in Liver Transplantation.

A recent systematic review published in Hepatology found no new safety or efficacy concerns for lipiodol transarterial chemoembolization in treating patients with hepatocellular carcinoma.